{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T20:47:48Z","timestamp":1786654068910,"version":"build-2736575974"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T00:00:00Z","timestamp":1738627200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T00:00:00Z","timestamp":1738627200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod Biol Endocrinol"],"DOI":"10.1186\/s12958-025-01346-7","type":"journal-article","created":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T10:42:29Z","timestamp":1738665749000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Cardiovascular disease risk prediction by Framingham risk score in women with polycystic ovary syndrome"],"prefix":"10.1186","volume":"23","author":[{"given":"Mina","family":"Amiri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Mousavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahsa","family":"Noroozzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fereidoun","family":"Azizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahimeh","family":"Ramezani Tehrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,4]]},"reference":[{"key":"1346_CR1","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/S0140-6736(19)32008-2","volume":"395","author":"S Yusuf","year":"2020","unstructured":"Yusuf S, Joseph P, Rangarajan S, Islam S, Mente A, Hystad P, et al. Modifiable risk factors, cardiovascular disease, and mortality in 155\u2008722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study. Lancet. 2020;395:795\u2013808.","journal-title":"Lancet"},{"key":"1346_CR2","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1016\/S0140-6736(18)32203-7","volume":"392","author":"D Bisanzio","year":"2018","unstructured":"Bisanzio D, Shokraneh F, Collaborators GCD. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980\u20132017: a systematic analysis for the global burden of Disease Study 2017. Lancet. 2018;392:1736\u201388.","journal-title":"Lancet"},{"key":"1346_CR3","first-page":"105","volume":"15","author":"P Samaniyan Bavarsad","year":"2020","unstructured":"Samaniyan Bavarsad P, Kheiri S, Ahmadi A. Estimation of the 10-Year risk of Cardiovascular diseases: using the SCORE, WHO\/ISH, and Framingham models in the Shahrekord Cohort Study in Southwestern Iran. J Tehran Heart Cent. 2020;15:105\u201312.","journal-title":"J Tehran Heart Cent"},{"key":"1346_CR4","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1161\/CIRCULATIONAHA.107.699579","volume":"117","author":"RB D\u2019Agostino","year":"2008","unstructured":"D\u2019Agostino RB, Sr., Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, et al. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation. 2008;117:743\u201353.","journal-title":"Circulation"},{"key":"1346_CR5","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.ijcard.2018.11.001","volume":"283","author":"C Wallisch","year":"2019","unstructured":"Wallisch C, Heinze G, Rinner C, Mundigler G, Winkelmayer WC, Dunkler D. External validation of two Framingham cardiovascular risk equations and the pooled cohort equations: a nationwide registry analysis. Int J Cardiol. 2019;283:165\u201370.","journal-title":"Int J Cardiol"},{"key":"1346_CR6","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.ijcard.2014.07.066","volume":"176","author":"S Selvarajah","year":"2014","unstructured":"Selvarajah S, Kaur G, Haniff J, Cheong KC, Hiong TG, van der Graaf Y, et al. Comparison of the Framingham risk score, SCORE and WHO\/ISH cardiovascular risk prediction models in an Asian population. Int J Cardiol. 2014;176:211\u20138.","journal-title":"Int J Cardiol"},{"key":"1346_CR7","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1111\/j.1742-1241.2010.02529.x","volume":"65","author":"M Bozorgmanesh","year":"2011","unstructured":"Bozorgmanesh M, Hadaegh F, Azizi F. Predictive accuracy of the \u2018Framingham\u2019s general CVD algorithm\u2019 in a Middle Eastern population: Tehran lipid and glucose study. Int J Clin Pract. 2011;65:264\u201373.","journal-title":"Int J Clin Pract"},{"key":"1346_CR8","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1161\/CIRCULATIONAHA.111.075929","volume":"125","author":"NR Cook","year":"2012","unstructured":"Cook NR, Paynter NP, Eaton CB, Manson JE, Martin LW, Robinson JG, et al. Comparison of the Framingham and Reynolds Risk scores for global cardiovascular risk prediction in the multiethnic women\u2019s Health Initiative. Circulation. 2012;125:1748\u201356.","journal-title":"Circulation"},{"key":"1346_CR9","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1177\/0145721715572154","volume":"41","author":"CJ Kim","year":"2015","unstructured":"Kim CJ, Kang HS, Schlenk EA, Chae SM. Assessment of cardiovascular risk in adults with type 2 diabetes and metabolic syndrome: Framingham versus UKPDS equations. Diabetes Educ. 2015;41:203\u201313.","journal-title":"Diabetes Educ"},{"key":"1346_CR10","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1177\/2047487312449307","volume":"21","author":"E Zomer","year":"2014","unstructured":"Zomer E, Liew D, Owen A, Magliano DJ, Ademi Z, Reid CM. Cardiovascular risk prediction in a population with the metabolic syndrome: Framingham vs. UKPDS algorithms. Eur J Prev Cardiol. 2014;21:384\u201390.","journal-title":"Eur J Prev Cardiol"},{"key":"1346_CR11","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1080\/09513590.2019.1650337","volume":"36","author":"F Ramezani Tehrani","year":"2020","unstructured":"Ramezani Tehrani F, Amiri M, Behboudi-Gandevani S, Bidhendi-Yarandi R, Carmina E. Cardiovascular events among reproductive and menopausal age women with polycystic ovary syndrome: a systematic review and meta-analysis. Gynecol Endocrinol. 2020;36:12\u201323.","journal-title":"Gynecol Endocrinol"},{"key":"1346_CR12","doi-asserted-by":"publisher","first-page":"e3369","DOI":"10.1210\/clinem\/dgab392","volume":"106","author":"TR Berni","year":"2021","unstructured":"Berni TR, Morgan CL, Rees DA. Women with polycystic ovary Syndrome have an increased risk of Major Cardiovascular events: a Population Study. J Clin Endocrinol Metab. 2021;106:e3369\u201380.","journal-title":"J Clin Endocrinol Metab"},{"key":"1346_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12958-020-00576-1","volume":"18","author":"M Amiri","year":"2020","unstructured":"Amiri M, Ramezani Tehrani F, Behboudi-Gandevani S, Bidhendi-Yarandi R, Carmina E. Risk of hypertension in women with polycystic ovary syndrome: a systematic review, meta-analysis and meta-regression. Reprod Biol Endocrinol. 2020;18:1\u201315.","journal-title":"Reprod Biol Endocrinol"},{"key":"1346_CR14","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1210\/clinem\/dgad356","volume":"109","author":"F Bril","year":"2023","unstructured":"Bril F, Ezeh U, Amiri M, Hatoum S, Pace L, Chen Y-H, et al. Adipose tissue dysfunction in polycystic ovary syndrome. J Clin Endocrinol Metabol. 2023;109:10\u201324.","journal-title":"J Clin Endocrinol Metabol"},{"key":"1346_CR15","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1097\/AOG.0000000000002698","volume":"132","author":"R Azziz","year":"2018","unstructured":"Azziz R. Polycystic ovary syndrome. Obstet Gynecol. 2018;132:321\u201336.","journal-title":"Obstet Gynecol"},{"key":"1346_CR16","first-page":"55","volume":"16","author":"D Macut","year":"2020","unstructured":"Macut D, Mladenovic V, Bjekic-Macut J, Livadas S, Stanojlovi\u0107 O, Hrn\u010dic D, et al. Hypertension in polycystic ovary syndrome: novel insights. Curr Hypertens Rev. 2020;16:55\u201360.","journal-title":"Curr Hypertens Rev"},{"key":"1346_CR17","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.steroids.2011.12.002","volume":"77","author":"RA Wild","year":"2012","unstructured":"Wild RA. Dyslipidemia in PCOS. Steroids. 2012;77:295\u20139.","journal-title":"Steroids"},{"key":"1346_CR18","doi-asserted-by":"publisher","unstructured":"Teede HT, Laven CT, Dokras J, Moran A, Piltonen L, Costello T. M. International Evidence-based Guideline for the assessment and management of polycystic ovary syndrome 2023. 2023. https:\/\/doi.org\/10.26180\/24003834.v1","DOI":"10.26180\/24003834.v1"},{"key":"1346_CR19","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.fertnstert.2013.10.055","volume":"101","author":"JK Hillman","year":"2014","unstructured":"Hillman JK, Johnson LN, Limaye M, Feldman RA, Sammel M, Dokras A. Black women with polycystic ovary syndrome (PCOS) have increased risk for metabolic syndrome and cardiovascular disease compared with white women with PCOS [corrected]. Fertil Steril. 2014;101:530\u20135.","journal-title":"Fertil Steril"},{"key":"1346_CR20","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1111\/cen.14117","volume":"92","author":"C Meun","year":"2020","unstructured":"Meun C, Gunning MN, Louwers YV, Peters H, Roos-Hesselink J, van Roeters J, et al. The cardiovascular risk profile of middle\u2010aged women with polycystic ovary syndrome. Clin Endocrinol. 2020;92:150\u20138.","journal-title":"Clin Endocrinol"},{"key":"1346_CR21","first-page":"e84786","volume":"16","author":"FR Tehrani","year":"2018","unstructured":"Tehrani FR, Behboudi-Gandevani S, Dovom MR, Farahmand M, Minooee S, Noroozzadeh M, et al. Reproductive assessment: findings from 20 years of the Tehran lipid and glucose study. Int J Endocrinol Metab. 2018;16:e84786.","journal-title":"Int J Endocrinol Metab"},{"key":"1346_CR22","doi-asserted-by":"publisher","first-page":"e105804","DOI":"10.1371\/journal.pone.0105804","volume":"9","author":"D Khalili","year":"2014","unstructured":"Khalili D, Haj Sheikholeslami F, Bakhtiyari M, Azizi F, Momenan AA, Hadaegh F. The incidence of coronary heart disease and the population attributable fraction of its risk factors in Tehran: a 10-year population-based cohort study. PLoS ONE. 2014;9:e105804.","journal-title":"PLoS ONE"},{"key":"1346_CR23","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","volume":"81","author":"E Rotterdam","year":"2004","unstructured":"Rotterdam E. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81:19\u201325.","journal-title":"Fertil Steril"},{"key":"1346_CR24","doi-asserted-by":"publisher","first-page":"3","DOI":"10.4103\/2008-7802.151433","volume":"6","author":"M Delshad","year":"2015","unstructured":"Delshad M, Ghanbarian A, Ghaleh NR, Amirshekari G, Askari S, Azizi F. Reliability and validity of the modifiable activity questionnaire for an Iranian urban adolescent population. Int J Prev Med. 2015;6:3.","journal-title":"Int J Prev Med"},{"key":"1346_CR25","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1097\/GME.0000000000001513","volume":"27","author":"M Amiri","year":"2020","unstructured":"Amiri M, Tehrani FR, Rahmati M, Firouzi F, Azizi F. Do trends of adiposity and metabolic parameters vary in women with different ovarian reserve status? A population-based cohort study. Menopause. 2020;27:684\u201392.","journal-title":"Menopause"},{"key":"1346_CR26","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1097\/01.hjr.0000216552.81882.ca","volume":"13","author":"F Hadaegh","year":"2006","unstructured":"Hadaegh F, Harati H, Ghanbarian A, Azizi F. Association of total cholesterol versus other serum lipid parameters with the short-term prediction of cardiovascular outcomes: Tehran lipid and glucose study. Eur J Prev Cardiol. 2006;13:571\u20137.","journal-title":"Eur J Prev Cardiol"},{"key":"1346_CR27","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","volume":"81","author":"TR ESHRE","year":"2004","unstructured":"ESHRE TR, Group A-SPCW. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81:19\u201325.","journal-title":"Fertil Steril"},{"key":"1346_CR28","doi-asserted-by":"publisher","first-page":"2578","DOI":"10.1056\/NEJMcp033496","volume":"353","author":"RL Rosenfield","year":"2005","unstructured":"Rosenfield RL, Hirsutism. N Engl J Med. 2005;353:2578\u201388.","journal-title":"N Engl J Med"},{"key":"1346_CR29","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1210\/jc.2003-032046","volume":"89","author":"R Azziz","year":"2004","unstructured":"Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO. The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab. 2004;89:2745\u20139.","journal-title":"J Clin Endocrinol Metab"},{"key":"1346_CR30","doi-asserted-by":"publisher","first-page":"bvac003","DOI":"10.1210\/jendso\/bvac003","volume":"6","author":"E Carmina","year":"2022","unstructured":"Carmina E, Dreno B, Lucky WA, Agak WG, Dokras A, Kim JJ, et al. Female adult acne and androgen excess: a Report from the multidisciplinary androgen excess and PCOS Committee. J Endocr Soc. 2022;6:bvac003.","journal-title":"J Endocr Soc"},{"key":"1346_CR31","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.ejogrb.2013.09.029","volume":"172","author":"S Hashemi","year":"2014","unstructured":"Hashemi S, Tehrani FR, Noroozzadeh M, Azizi F. Normal cut-off values for hyperandrogenaemia in Iranian women of reproductive age. Eur J Obstet Gynecol Reprod Biol. 2014;172:51\u20135.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"1346_CR32","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1093\/humrep\/deg115","volume":"18","author":"S Jonard","year":"2003","unstructured":"Jonard S, Robert Y, Cortet-Rudelli C, Pigny P, Decanter C, Dewailly D. Ultrasound examination of polycystic ovaries: is it worth counting the follicles? Hum Reprod. 2003;18:598\u2013603.","journal-title":"Hum Reprod"},{"key":"1346_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2377-12-117","volume":"12","author":"N Fahimfar","year":"2012","unstructured":"Fahimfar N, Khalili D, Mohebi R, Azizi F, Hadaegh F. Risk factors for ischemic stroke; results from 9 years of follow-up in a population based cohort of Iran. BMC Neurol. 2012;12:1\u20137.","journal-title":"BMC Neurol"},{"key":"1346_CR34","doi-asserted-by":"publisher","first-page":"S67","DOI":"10.2337\/dc13-S067","volume":"36","author":"AD Association","year":"2013","unstructured":"Association AD. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2013;36:S67\u201374.","journal-title":"Diabetes Care"},{"key":"1346_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ypmed.2014.04.010","volume":"65","author":"J Jih","year":"2014","unstructured":"Jih J, Mukherjea A, Vittinghoff E, Nguyen TT, Tsoh JY, Fukuoka Y, et al. Using appropriate body mass index cut points for overweight and obesity among Asian americans. Prev Med. 2014;65:1\u20136.","journal-title":"Prev Med"},{"key":"1346_CR36","unstructured":"Li Y, Shen S. Cardiovascular risk assessment in polycystic ovary syndrome based on Framingham score. J Pract Obstet Gynecol. 2019;12: 298-301."},{"key":"1346_CR37","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1111\/cen.14117","volume":"92","author":"C Meun","year":"2020","unstructured":"Meun C, Gunning MN. The cardiovascular risk profile of middle-aged women with polycystic ovary syndrome. Clin Endocrinol (Oxf). 2020;92:150\u20138.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1346_CR38","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/0002-8703(91)90861-B","volume":"121","author":"KM Anderson","year":"1991","unstructured":"Anderson KM, Odell PM, Wilson PW, Kannel WB. Cardiovascular disease risk profiles. Am Heart J. 1991;121:293\u20138.","journal-title":"Am Heart J"},{"key":"1346_CR39","doi-asserted-by":"publisher","first-page":"249","DOI":"10.21608\/ejom.2021.193283","volume":"45","author":"MB Awad Allah","year":"2021","unstructured":"Awad Allah MB, Khalil WA. Cardiovascular diseases Risk Prediction using the Framingham risk score. Egypt J Occup Med. 2021;45:249\u201364.","journal-title":"Egypt J Occup Med"},{"key":"1346_CR40","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1111\/j.1478-3231.2011.02753.x","volume":"32","author":"S Treeprasertsuk","year":"2012","unstructured":"Treeprasertsuk S, Leverage S, Adams LA, Lindor KD, St Sauver J, Angulo P. The Framingham risk score and heart disease in nonalcoholic fatty liver disease. Liver Int. 2012;32:945\u201350.","journal-title":"Liver Int"},{"key":"1346_CR41","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.numecd.2019.10.010","volume":"30","author":"A Santos","year":"2020","unstructured":"Santos A, Rodrigues APS, Rosa LPS, Sarrafzadegan N, Silveira EA. Cardiometabolic risk factors and Framingham Risk score in severely obese patients: baseline data from DieTBra trial. Nutr Metab Cardiovasc Dis. 2020;30:474\u201382.","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"1346_CR42","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1161\/01.CIR.67.5.968","volume":"67","author":"HB Hubert","year":"1983","unstructured":"Hubert HB, Feinleib M, McNamara PM, Castelli WP. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation. 1983;67:968\u201377.","journal-title":"Circulation"},{"key":"1346_CR43","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1161\/01.CIR.0000161956.75255.7B","volume":"111","author":"S Mora","year":"2005","unstructured":"Mora S, Yanek LR, Moy TF, Fallin MD, Becker LC, Becker DM. Interaction of body mass index and framingham risk score in predicting incident coronary disease in families. Circulation. 2005;111:1871\u20136.","journal-title":"Circulation"},{"key":"1346_CR44","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1093\/humupd\/dmaa029","volume":"26","author":"V Wekker","year":"2020","unstructured":"Wekker V, van Dammen L, Koning A, Heida KY, Painter RC, Limpens J, et al. Long-term cardiometabolic disease risk in women with PCOS: a systematic review and meta-analysis. Hum Reprod Update. 2020;26:942\u201360.","journal-title":"Hum Reprod Update"},{"key":"1346_CR45","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1210\/er.2007-0006","volume":"28","author":"R Muniyappa","year":"2007","unstructured":"Muniyappa R, Montagnani M, Koh KK, Quon MJ. Cardiovascular actions of insulin. Endocr Rev. 2007;28:463\u201391.","journal-title":"Endocr Rev"},{"key":"1346_CR46","doi-asserted-by":"publisher","first-page":"e3561","DOI":"10.1016\/j.amjmed.2005.10.059","volume":"119","author":"E Carmina","year":"2006","unstructured":"Carmina E, Orio F, Palomba S, Longo RA, Cascella T, Colao A, et al. Endothelial dysfunction in PCOS: role of obesity and adipose hormones. Am J Med. 2006;119:e3561\u20136.","journal-title":"Am J Med"},{"key":"1346_CR47","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3389\/fendo.2013.00037","volume":"4","author":"ME Cerf","year":"2013","unstructured":"Cerf ME. Beta cell dysfunction and insulin resistance. Front Endocrinol (Lausanne). 2013;4:37.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1346_CR48","doi-asserted-by":"publisher","first-page":"384","DOI":"10.3389\/fendo.2018.00384","volume":"9","author":"YS Oh","year":"2018","unstructured":"Oh YS, Bae GD, Baek DJ, Park E-Y, Jun H-S. Fatty acid-induced lipotoxicity in pancreatic beta-cells during development of type 2 diabetes. Front Endocrinol. 2018;9:384.","journal-title":"Front Endocrinol"},{"key":"1346_CR49","doi-asserted-by":"publisher","first-page":"33715","DOI":"10.18632\/oncotarget.9553","volume":"7","author":"L Zhao","year":"2016","unstructured":"Zhao L, Zhu Z, Lou H, Zhu G, Huang W, Zhang S, et al. Polycystic ovary syndrome (PCOS) and the risk of coronary heart disease (CHD): a meta-analysis. Oncotarget. 2016;7:33715\u201321.","journal-title":"Oncotarget"},{"key":"1346_CR50","first-page":"521","volume":"3","author":"J Tu\u00f1\u00f3n","year":"2007","unstructured":"Tu\u00f1\u00f3n J, Luis Mart\u00edn-Ventura J, Blanco-Colio LM, Tarin N, Egido J. Common pathways of hypercholesterolemia and hypertension leading to atherothrombosis: the need for a global approach in the management of cardiovascular risk factors. Vasc Health Risk Manag. 2007;3:521\u20136.","journal-title":"Vasc Health Risk Manag"},{"key":"1346_CR51","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1093\/ejendo\/lvad077","volume":"189","author":"M-M Ollila","year":"2023","unstructured":"Ollila M-M, Arffman RK, Korhonen E, Morin-Papunen L, Franks S, Junttila J, et al. Women with PCOS have an increased risk for cardiovascular disease regardless of diagnostic criteria\u2014a prospective population-based cohort study. Eur J Endocrinol. 2023;189:96\u2013105.","journal-title":"Eur J Endocrinol"},{"key":"1346_CR52","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1093\/ejendo\/lvad067","volume":"188","author":"AK Dwivedi","year":"2023","unstructured":"Dwivedi AK, Vishwakarma D, Dubey P, Reddy S. Association of polycystic ovary syndrome with cardiovascular disease among female hospitalizations in the United States. Eur J Endocrinol. 2023;188:555\u201363.","journal-title":"Eur J Endocrinol"},{"key":"1346_CR53","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1089\/jwh.2015.5441","volume":"25","author":"CNB Merz","year":"2016","unstructured":"Merz CNB, Shaw LJ, Azziz R, Stanczyk FZ, Sopko G, Braunstein GD, et al. Cardiovascular disease and 10-year mortality in postmenopausal women with clinical features of polycystic ovary syndrome. J Women\u2019s Health. 2016;25:875\u201381.","journal-title":"J Women\u2019s Health"},{"key":"1346_CR54","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1210\/js.2018-00205","volume":"3","author":"MC Jim\u00e9nez","year":"2019","unstructured":"Jim\u00e9nez MC, Tucker KL, Rodriguez F, Porneala BC, Meigs JB, L\u00f3pez L. Cardiovascular risk factors and dehydroepiandrosterone sulfate among latinos in the Boston Puerto Rican Health Study. J Endocr Soc. 2019;3:291\u2013303.","journal-title":"J Endocr Soc"},{"key":"1346_CR55","doi-asserted-by":"publisher","first-page":"3537545","DOI":"10.21037\/apm-20-441","volume":"9","author":"R Li","year":"2020","unstructured":"Li R, Lihua E, Zha N. Circulating dehydroepiandrosterone sulfate level and cardiovascular or all-cause mortality in the elderly population: a meta-analysis. Ann Palliat Med. 2020;9:3537545\u20133545.","journal-title":"Ann Palliat Med"},{"key":"1346_CR56","doi-asserted-by":"publisher","first-page":"e4304","DOI":"10.1210\/clinem\/dgaa518","volume":"105","author":"X Jia","year":"2020","unstructured":"Jia X, Sun C, Tang O, Gorlov I, Nambi V, Virani SS, et al. Plasma Dehydroepiandrosterone Sulfate and Cardiovascular Disease Risk in Older men and women. J Clin Endocrinol Metab. 2020;105:e4304\u201327.","journal-title":"J Clin Endocrinol Metab"},{"key":"1346_CR57","doi-asserted-by":"publisher","first-page":"e1370","DOI":"10.1038\/cddis.2014.337","volume":"5","author":"R Chen","year":"2014","unstructured":"Chen R, Kang R, Fan XG, Tang D. Release and activity of histone in diseases. Cell Death Dis. 2014;5:e1370.","journal-title":"Cell Death Dis"},{"key":"1346_CR58","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1016\/S0140-6736(94)92587-9","volume":"343","author":"P Ebeling","year":"1994","unstructured":"Ebeling P, Koivisto VA. Physiological importance of dehydroepiandrosterone. Lancet. 1994;343:1479\u201381.","journal-title":"Lancet"},{"key":"1346_CR59","doi-asserted-by":"publisher","first-page":"100008","DOI":"10.1016\/j.ajpc.2020.100008","volume":"1","author":"ND Wong","year":"2020","unstructured":"Wong ND. Cardiovascular risk assessment: the foundation of preventive cardiology. Am J Prev Cardiol. 2020;1:100008.","journal-title":"Am J Prev Cardiol"},{"key":"1346_CR60","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1016\/j.cjca.2016.07.510","volume":"32","author":"TJ Anderson","year":"2016","unstructured":"Anderson TJ, Gr\u00e9goire J, Pearson GJ, Barry AR, Couture P, Dawes M, et al. 2016 Canadian Cardiovascular Society Guidelines for the management of Dyslipidemia for the Prevention of Cardiovascular Disease in the adult. Can J Cardiol. 2016;32:1263\u201382.","journal-title":"Can J Cardiol"},{"key":"1346_CR61","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.ypmed.2017.03.004","volume":"99","author":"LR Turner","year":"2017","unstructured":"Turner LR, Cicuttini F, Pearce C, Mazza D. Cardiovascular disease screening in general practice: General practitioner recording of common risk factors. Prev Med. 2017;99:282\u20135.","journal-title":"Prev Med"}],"container-title":["Reproductive Biology and Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12958-025-01346-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12958-025-01346-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12958-025-01346-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T10:44:20Z","timestamp":1738665860000},"score":1,"resource":{"primary":{"URL":"https:\/\/rbej.biomedcentral.com\/articles\/10.1186\/s12958-025-01346-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,4]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1346"],"URL":"https:\/\/doi.org\/10.1186\/s12958-025-01346-7","relation":{},"ISSN":["1477-7827"],"issn-type":[{"value":"1477-7827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,4]]},"assertion":[{"value":"25 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research project was approved by the Medical Ethics Committee of the Research Institute for Endocrine Sciences (IR.SBMU.ENDOCRINE.REC.1402.085). All participants signed the written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"19"}}